TY - JOUR
T1 - Characterization and molecular modeling of a highly stable anti-Hepatitis B surface antigen scFv
AU - Bose, Biplab
AU - Chugh, Dipti A.
AU - Kala, Mrinalini
AU - Acharya, Subrat K.
AU - Khanna, Navin
AU - Sinha, Subrata
N1 - Funding Information:
This work has been funded from research grants from the Department of Biotechnology, India and Indian Council of Medical Research, India. We thank Prof. Greg Winter for kindly gifting us the vector pHEN1, and Dr Vijay Chaudhary for his gift of anti-M13 monoclonal antibody. We also thank Ashutosh Tiwari for helpful discussion and help during isolation of clones. We are thankful to M/s Mathura Prasad and Satish for their technical and secretarial assistance.
PY - 2003/12
Y1 - 2003/12
N2 - We raised a mouse monoclonal antibody (5S) against the 'a' epitope of the Hepatitis B surface antigen (HBsAg) by selecting for binding of the hybridoma supernatant in conditions that usually destabilize protein-protein interactions. This antibody, which was protective in an in vitro assay, had a high affinity with a relative dissociation constant in the nanomolar range. It also displayed stable binding to antigen in conditions that usually destabilize antigen-antibody interactions, like 30% DMSO, 8M urea, 4M NaCl, 1M guanidium HCl and extremes of pH. The variable regions of the antibody were cloned and expressed as an single chain variable fragment (scFv) (A5). A5 had a relative affinity comparable to the mouse monoclonal and showed antigen binding in presence of 20% DMSO, 8M urea and 3M NaCl. It bound the antigen in the pH range of 6-8, though its tolerance for guanidium HCl was reduced. Sequence analysis demonstrated a significant increase in the frequency of somatic replacement mutations in CDRs over framework regions in the light but not in the heavy chain. A comparison of the molecular models of the variable regions of the 5S antibody and its germ-line precurser revealed that critical mutations in the heavy and light chains interface resulted in better inter-chain packing and in the movement of CDR H3 and CDR L1 from their germline positions, which may be important for better antigen binding. In addition to providing a reagent for neutralizing for the virus, such an antibody provides a model for the evolution of stable high affinity interaction during antibody maturation.
AB - We raised a mouse monoclonal antibody (5S) against the 'a' epitope of the Hepatitis B surface antigen (HBsAg) by selecting for binding of the hybridoma supernatant in conditions that usually destabilize protein-protein interactions. This antibody, which was protective in an in vitro assay, had a high affinity with a relative dissociation constant in the nanomolar range. It also displayed stable binding to antigen in conditions that usually destabilize antigen-antibody interactions, like 30% DMSO, 8M urea, 4M NaCl, 1M guanidium HCl and extremes of pH. The variable regions of the antibody were cloned and expressed as an single chain variable fragment (scFv) (A5). A5 had a relative affinity comparable to the mouse monoclonal and showed antigen binding in presence of 20% DMSO, 8M urea and 3M NaCl. It bound the antigen in the pH range of 6-8, though its tolerance for guanidium HCl was reduced. Sequence analysis demonstrated a significant increase in the frequency of somatic replacement mutations in CDRs over framework regions in the light but not in the heavy chain. A comparison of the molecular models of the variable regions of the 5S antibody and its germ-line precurser revealed that critical mutations in the heavy and light chains interface resulted in better inter-chain packing and in the movement of CDR H3 and CDR L1 from their germline positions, which may be important for better antigen binding. In addition to providing a reagent for neutralizing for the virus, such an antibody provides a model for the evolution of stable high affinity interaction during antibody maturation.
KW - Anti-HBs antibody
KW - Molecular modeling
KW - Protein-protein interactions
KW - Recombinant antibody
KW - Somatic mutations
UR - http://www.scopus.com/inward/record.url?scp=0142195846&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0142195846&partnerID=8YFLogxK
U2 - 10.1016/j.molimm.2003.07.002
DO - 10.1016/j.molimm.2003.07.002
M3 - Article
C2 - 14597165
AN - SCOPUS:0142195846
SN - 0161-5890
VL - 40
SP - 617
EP - 631
JO - Molecular Immunology
JF - Molecular Immunology
IS - 9
ER -